Testing effectiveness (Phase 2)Study completedNCT00163085
What this trial is testing
The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease
Who this might be right for
Parkinson's Disease
Pfizer 12
Showing 8 of 8 results